Logo Image

Armando Gamboa-Domínguez, MD

Articles by Armando Gamboa-Domínguez, MD

Evaluating HRR and MMR in Advanced Prostate Cancer: © Sebastian Kaulitzki - stock.adobe.com

Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City

ByJosé Luis Rodríguez-Olivares, MD,Mauricio Mora Pineda, MD,Evelyn Beas-Lozano, MD,Alec Seidman-Sorsby, MD,Yuly A. Remolina-Bonilla, MD, MSc,Armando Gamboa-Domínguez, MD,Jeffrey Weitzel, MD, FACMG,Pedro Barata, MD, MSc,Yanin Chavarri-Guerra, MD, MSc, FASCO,María T. Bourlon, MD, MSc, FASCO

This cross-sectional study evaluated the genetic landscape of a cohort of patients with metastatic prostate cancer who were treated at a referral center in Mexico City, Mexico.

Sjögren Syndrome Induced by Immune Checkpoint Inhibitors in a Patient with Advanced Renal Cell Carcinoma

ByEmilio Conde-Flores, MD,Yuly A. Remolina-Bonilla, MD, MSc,Francisco J. Castro-Alonso, MD,Nayeli A. Martínez-Ibarra, MS,Gabriela Hernández-Molina, MD,Mónica Chapa-Ibargüengoitia, MD,Armando Gamboa-Domínguez, MD,María T. Bourlon, MD, MSc, FASCO

This clinical quandary details a Mexican man, aged 77 years, who presented to the oncology clinic with a sternal mass. Based on the results, the patient fulfilled the 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for Sjögren syndrome, thus the diagnosis triggered by immune checkpoint inhibitors was definitively established.

Latest Updated Articles